News Daily News Less Bivalirudin, Minimal Ultrasound: Survey Highlights Global Transradial Practice Patterns Michael O'Riordan November 28, 2018
News Conference News CRT 2018 Time to Shine: ‘Historic’ All-Female Team Takes Over Live Case at CRT 2018 Michael O'Riordan March 06, 2018
News Industry News Medtronic Launches First 2.0 mm Drug-Eluting Stent in United States Designed to Treat Patients with Small Vessels February 26, 2018
News Industry News Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology August 15, 2017
News Industry News Medtronic RESOLUTE ONYX(TM) 2.0 mm Clinical Study Meets Primary Endpoint in Extra-Small Vessels at One-Year May 18, 2017
News Conference News SCAI 2017 Bioresorbable Scaffolds: Where Do We Go From Here? L.A. McKeown May 15, 2017
News Industry News Medtronic Launches Resolute Onyx(TM) Drug-Eluting Stent in United States Following FDA Approval Becoming First DES Available in 4.5 mm and 5 mm Sizes May 02, 2017
Presentation JIM 2016 MiStent: Evolution of Drug Elution with Crystalline Sirolimus Presenter: Davide Capodanno February 10, 2016
Presentation JIM 2016 Can we Bury the GHOST? Practice evolution with BRS Presenter: Corrado Tamburino February 10, 2016
News Conference News TCT 2015 Debaters Question Need for Further Stent Innovation Todd Neale October 13, 2015
News Conference News TCT 2015 BIOSOLVE-II: Novel Absorbable Scaffold Safe, Effective October 12, 2015
News Conference News TCT 2015 Novel Devices Present New Treatment Options for STEMI Yael L. Maxwell October 11, 2015
News Industry News Medtronic to Unveil New Clinical Data for its Innovative Portfolio of Interventional Technologies at TCT 2015 October 07, 2015
News Industry News Boston Scientific Receives FDA Approval For SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System October 05, 2015
News Industry News Abbott Announces Positive Results Of Its Naturally Dissolving Stent From Absorb Japan Study September 01, 2015
News Daily News No Disadvantage for 2-Stent Strategy in Bifurcation Lesions With Second-Generation DES Yael L. Maxwell August 26, 2015
Presentation Keynote Lecture I:Evolution of InterventionalTherapies and Future Directions Presenter: Raoul Bonan July 11, 2015
News Daily News Moderate-to-Severe Mitral Regurgitation Signals Elevated Mortality Risk After TAVR Todd Neale June 18, 2015